References
- Habib MJ. Pharmaceutical solid dispersion technology. Pennsylvania: Technomic; 2001.
- Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068–75.
- Al-Obaidi H, Ke P, Brocchini S, Buckton G. Characterization and stability of ternary solid dispersions with PVP and PHPMA. Int J Pharm 2011;419:20–7.
- Martins RM, Siqueira S, Tacon LA, Freitas LAP. Microstructured ternary solid dispersions to improve carbamazepine solubility. Powder Technol 2012;215/216:156–65.
- Rashid R, Kim DW, Din F, et al. Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion. Carbohydr Polym 2015;130:26–31.
- Van den Mooter G. The use of amorphous solid dispersions: a formulation strategy to overcome poor solubility and dissolution rate. Drug Discov Today Technol 2011;9:e79–85.
- Urbanetz NA. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. Eur J Pharm Sci 2006; 28:67–76.
- Xie T, Taylor LS. Dissolution performance of high drug loading celecoxib amorphous solid dispersions formulated with polymer. Pharm Res 2016;33:739–50.
- Barmpalexis P, Koutsidis I, Karavas E, et al. Development of PVP/PEG mixtures as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique and optimization of dissolution using artificial neural networks. Eur J Pharm Biopharm 2013;85:1219–31.
- Szűts A, Láng P, Ambrus R, et al. Applicability of sucrose laurate as surfactant in solid dispersions prepared by melt technology. Int J Pharm 2011;410:107–10.
- Janssens S, Novoa de Armas H, D’Autry W, et al. Characterization of ternary solid dispersions of itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends. Eur J Pharm Biopharm 2008;69:1114–20.
- Janssens S, Roberts C, Smith EF, Van den Mooter G. Physical stability of ternary solid dispersions of itraconazole in polyethyleneglycol 6000/hydroxypropylmethylcellulose 2910 E5 blends . Int J Pharm 2008;355:100–7.
- Urbanetz NA, Lippold BC. Solid dispersions of nimodipine and polyethylene glycol 2000: dissolution properties and physico-chemical characterisation. Eur J Pharm Biopharm 2005;59:107–18.
- Gumaste SG, Gupta SS, Serajuddin ATM. Investigation of polymer-surfactant and polymer-drug-surfactant miscibility for solid dispersion. AAPS J 2016;18:1131–43.
- Sugimoto S, Niwa T, Nakanishi Y, Danjo K. Development of a novel ultra cryo-milling technique for a poorly water-soluble drug using dry ice beads and liquid nitrogen. Int J Pharm 2012;426:162–9.
- Li J, Miao X, Chen T, et al. Preparation and characterization of pelletized solid dispersion of resveratrol with mesoporous silica microparticles to improve dissolution by fluid-bed coating techniques. Asian J Pharm Sci 2016;11:528–35.
- Padalkar AN, Shahi SR, Kale AG, Tube M. Formulation and characterization of novel solid dispersions of hydrochlorothiazide by hot melt extrusion technique. J Biomed Pharm Res 2012;1:38–45.
- Hosaka S, Sato M, Ozawa Y, et al. Effect of compression on interaction between 1,4-dihydropyridine compounds and lactose monohydrate. Chem Pharm Bull 2005;53:503–7.
- Chamsai B, Sriamornsak P. Effect of biopolymer on the dissolution and stability of itraconazole. Adv Mater Res 2013; 747:115–18.
- Vasa DM, Dalal N, Katz JM, et al. Physical characterization of drug:polymer dispersion behavior in polyethylene glycol 4000 solid dispersions using a suite of complementary analytical techniques. J Pharm Sci 2014;103:2911–23.
- Kirkpatrick RJ. Crystal growth from the melt: a review. Am Mineral 1975;60:798–814.
- Vaka SRK, Bommana MM, Desai D, Djordjevic J, Phuapradit W, Shah N, Excipients for amorphous solid dispersions. In: Shah N., Sandhu H., Choi D.S., Chokshi H., Malick A.W. eds. Amorphous solid dispersions: theory and practice. London: Springer; 2014:123–163.
- Barboza FM, Machado WM, Junior LRO, et al. PCL/PHBV microparticles as innovative carriers for oral controlled release of manidipine dihydrochloride. Scientific World J 2014;2014:268107.
- Jog R, Gokhale R, Burgess DJ. Solid state drug-polymer miscibility studies using the model drug ABT-102. Int J Pharm 2016;509:285–95.
- Fini A, Moyano JR, Gines JM, et al. Diclofenac salts, II. Solid dispersions in PEG6000 and gelucire 50/13. Eur J Pharm Biopharm 2005;60:99–111.
- Song Y, Wang L, Yang P, et al. Physicochemical characterization of felodipine-kollidon VA64 amorphous solid dispersions prepared by hot-melt extrusion. J Pharm Sci 2013;102:1915–23.
- Newa M, Bhandari KH, Li DX, et al. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm 2007;343:228–37.
- Ghareeb MM, Abdulrasool AA, Hussein AA, Noordin MI. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS PharmSciTech 2009;10:1206–15.
- Ullah M, Ullah H, Murtaza G, et al. Evaluation of influence of various polymers on dissolution and phase behavior of carbamazepine-succinic acid cocrystal in matrix tablets. Biomed Res Int 2015;2015:870656.
- Gupta SS, Parikh T, Meena AK, et al. Effect of carbamazepine on viscoelastic properties and hot melt extrudability of Soluplus®. Int J Pharm 2015;478:232–9.
- Li M, Gogos CG, Ioannidis N. Improving the API dissolution rate during pharmaceutical hot-melt extrusion I: effect of the API particle size, and the co-rotating, twin-screw extruder screw configuration on the API dissolution rate. Int J Pharm 2015;478:103–12.
- Kalia A, Poddar M. Solid dispersions: an approach towards enhancing dissolution rate. Int J Pharm Pharm Sci 2011;3:9–19.